Particulars |
Company Name |
Concord Biotech Ltd |
Year End |
2023/03 |
Full Year |
Equity (Rs Cr.) |
10.46 |
B.V (Rs) |
129.40 |
Sales (Rs Cr.) |
853.17 |
NP. (Rs Cr.) |
235.43 |
NP Var% |
35.00 |
Div% |
683.00 |
CPS (Rs) |
27.70 |
EPS (Rs) |
22.50 |
Traded Value (Rs Lakhs) |
21.14 |
52 Week High |
1,712.00 |
52 Week Low |
900.00 |
Price BSE |
1,460.00 |
Price NSE |
1,458.00 |
Market Capital (Rs Cr.) |
15,269.26 |
P/C Ratio |
52.80 |
P/E Ratio |
64.90 |
Price Vs.BV |
11.28 |
|
Latest Quarter |
Year End |
202312 |
Sales (Rs Cr.) |
240.80 |
NP (Rs Cr.) |
74.55 |
NP Var % |
-6.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
0.00 |
OPM |
0.00 |
NP |
0.00 |
NP Var% |
|
EPS |
28.77 |
PE |
50.73 |
|
|